#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    ABO haemolytic disease of newborn Neonatal alloimmune thrombocytopenia Adenoid cystic carcinoma Hepato-lenticular degeneration B-cell lymphoma refractory Rheumatoid arthritis Gastrooesophageal cancer Chorioretinitis Chronic inflammatory demyelinating polyradiculoneuropathy Immunodeficiency congenital Neuroendocrine carcinoma metastatic Cutaneous T-cell lymphoma stage II Homocystinuria Stress cardiomyopathy Infertility male More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy Small intestine leiomyosarcoma VEXAS syndrome – Life with Disease Short-bowel syndrome – Life with Disease Tuberous sclerosis complex – Treatment Angiosarcoma – Diagnostics Lymphatic malformation – Life with Disease Pleomorphic leiomyosarcoma – Life with Disease Mantle cell lymphoma stage III Hereditary hypophosphataemic rickets – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cusatuzumab Aceclofenac Autologous Microfat GSK5764227 Enpatoran Delafloxacin Bempedoic Acid Glipizide Tamibarotene Folic Acid, Anhydrous [14C] DC-806 Epirubicin Hydrochloride Brodalumab Ribonucleic Acid K30 Adezunap Glucose Monohydrate Ph. Eur. Spartalizumab Dupilumab Clemastine Fumarate SARACATINIB More therapies…

    Learn about Your Condition

    Lung transplant Melanoma recurrent Rectal cancer stage II Enteritis Ewing's sarcoma metastatic Mitral valve incompetence Thyroid cancer metastatic Cardiogenic shock Cervix carcinoma recurrent Gastric cancer Epicondylitis Herpes simplex meningitis CDKL5 deficiency disorder Oral herpes Diminished ovarian reserve More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of upadacitinib in adults with erosive mucosal lichen planus and lichen planopilaris.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Lichen planus
    Investigated Drugs:
    • Upadacitinib
    France

  • A study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN VITRO EXPANDED
    Denmark

  • A study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Zasocitinib
    France Germany The Netherlands Poland

  • A study to evaluate the safety and effectiveness of urokinase, catalytic domain, fused with a single-chain antibody against von Willebrand factor in patients with immune-mediated thrombotic thrombocytopenic purpura.

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Thrombotic microangiopathy
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • UROKINASE, CATALYTIC DOMAIN, FUSED WITH A SINGLE-CHAIN ANTIBODY AGAINST VON WILLEBRAND FACTOR
    France Germany Italy Spain

  • Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Empagliflozin
    France

  • Study of dexamethasone injections for the management of chronic cervicobrachial neuralgia in adults who have not responded to standard medical treatments

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Dexamethasone
    France
Previous Page
1 … 736 737 738 739 740 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!